Determination of solifenacin in human plasma by liquid chromatography-tandem mass spectrometryMACEK, Jan; PTACEK, Pavel; KLIMA, Josef et al.Journal of chromatography. B. 2010, Vol 878, Num 31, pp 3327-3330, issn 1570-0232, 4 p.Article

Determination of solifenacin succinate, a novel muscarinic receptor antagonist, and its major metabolite in rat plasma by semi-micro high performance liquid chromatographyYANAGIHARA, Takamitsu; AOKI, Toshiko; SOEISHI, Yoshiaki et al.Journal of chromatography. B. 2007, Vol 859, Num 2, pp 241-245, issn 1570-0232, 5 p.Article

Solifenacin for overactive bladder with incontinence : Symptom bother and health-related quality of life outcomesGARELY, Alan D; LUCENTE, Vincent; VAPNEK, Jonathan et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 3, pp 391-399, issn 1060-0280, 9 p.Article

Solifenacin is effective for thetreatment of OAB dry patients : A pooled analysisABRAMS, Paul; SWIFT, Steven.European urology. 2005, Vol 48, Num 3, pp 483-487, issn 0302-2838, 5 p.Article

Redefining response in overactive bladder syndromePAYNE, Christopher K; KELLEHER, Con.BJU international (Papier). 2007, Vol 99, Num 1, pp 101-106, issn 1464-4096, 6 p.Article

In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in ratsOHTAKE, Akiyoshi; UKAI, Masashi; HATANAKA, Toshiki et al.European journal of pharmacology. 2004, Vol 492, Num 2-3, pp 243-250, issn 0014-2999, 8 p.Article

Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder : The VESIcare open-label trial (VOLT)GARELY, Alan D; KAUFMAN, Joel M; SAND, Peter K et al.Clinical therapeutics. 2006, Vol 28, Num 11, pp 1935-1946, issn 0149-2918, 12 p.Article

Pharmacokinetic effect of ketoconazole on solifenacin in healthy volunteersSWART, Pieter J; KRAUWINKEL, Walter J. J; SMULDERS, Ronald A et al.Basic & clinical pharmacology & toxicology (Print). 2006, Vol 99, Num 1, pp 33-36, issn 1742-7835, 4 p.Article

A Validated Rapid Stability-Indicating Method for the Determination of Related Substances in Solifenacin Succinate by Ultra-Fast Liquid ChromatographyKRISHNA, S. Radha; RAO, B. M; SOMESWARA RAO, N et al.Journal of chromatographic science. 2010, Vol 48, Num 10, pp 807-810, issn 0021-9665, 4 p.Article

Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in miceOKI, Tomomi; SATO, Shuichi; MIYATA, Keiji et al.British journal of pharmacology. 2005, Vol 145, Num 2, pp 219-227, issn 0007-1188, 9 p.Article

Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experienceWAGG, Adrian; COMPION, Gerhard; FAHEY, Amanda et al.BJU international (Papier). 2012, Vol 110, Num 11, pp 1767-1774, issn 1464-4096, 8 p.Article

Solifenacin succinate for the treatment of symptoms of overactive bladderMANISCALCO, Maria; SINGH-FRANCO, Devada; WOLOWICH, William R et al.Clinical therapeutics. 2006, Vol 28, Num 9, pp 1247-1272, issn 0149-2918, 26 p.Article

Comparison of muscarinic receptor selectivity of solifenacin and oxybutynin in the bladder and submandibular gland of muscarinic receptor knockout miceITO, Yoshihiko; OYUNZUL, Luvsandorj; YAMADA, Shizuo et al.European journal of pharmacology. 2009, Vol 615, Num 1-3, pp 201-206, issn 0014-2999, 6 p.Article

Muscarinic receptors in the bladder : from basic research to therapeuticsHEGDE, Sharath S.British journal of pharmacology. 2006, Vol 147, issn 0007-1188, S80-S87, SUP2Conference Paper

Persistence with antimuscarinic therapy in patients with overactive bladderHAAB, F; CASTRO-DIAZ, D.International journal of clinical practice (Esher). 2005, Vol 59, Num 8, pp 931-937, issn 1368-5031, 7 p.Article

Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo- and tolterodine-controlled phase 2 dose-finding studyCHAPPLE, C. R; ARANO, P; BOSCH, J. L. H. R et al.BJU international (Papier). 2004, Vol 93, Num 1, pp 71-77, issn 1464-4096, 7 p.Article

Safety and Tolerability of Solifenacin Add-on Therapy to α-Blocker Treated Men With Residual Urgency and FrequencyKAPLAN, Steven A; MCCAMMON, Kurt; FINCHER, Roger et al.The Journal of urology. 2009, Vol 182, Num 6, pp 2825-2830, issn 0022-5347, 6 p., 1Article

Solifenacin in overactive bladder syndromeSIMPSON, Dene; WAGSTAFF, Antona J.Drugs & aging. 2005, Vol 22, Num 12, pp 1061-1069, issn 1170-229X, 9 p.Article

Solifénacine (Vesicare) : hyperactivité vésicale : 5e anticholinergique, d'intérêt clinique douteux = Solifenacin (Vesicare): overactive bladder: 5th anticholinergic, uncertain clinical interestLa Revue Prescrire. 2005, Vol 25, Num 261, pp 336-338, issn 0247-7750, 3 p.Article

Cost-effectiveness analysis of solifenacin flexible dosing in patients with overactive bladder symptoms in four Nordic countriesMILSOM, Ian; AXELSEN, Susanne; KULSENG-HANSEN, Sigurd et al.Acta obstetricia et gynecologica scandinavica. 2009, Vol 88, Num 6, pp 693-699, issn 0001-6349, 7 p.Article

Muscarinic receptor antagonists for overactive bladderABRAMS, Paul; ANDERSSON, Karl-Erik.BJU international (Papier). 2007, Vol 100, Num 5, pp 987-1006, issn 1464-4096, 20 p.Article

Effect of antimuscarinic drugs used for overactive bladder on learning in a rat passive avoidance response testSUZUKI, Masanori; NOGUCHI, Yukiko; OKUTSU, Hiroko et al.European journal of pharmacology. 2007, Vol 557, Num 2-3, pp 154-158, issn 0014-2999, 5 p.Article

Solifenacin Plus Tamsulosin Combination Treatment in Men With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction: A Randomized Controlled TrialKAPLAN, Steven A; WEIZHONG HE; KOLTUN, William D et al.European urology. 2013, Vol 63, Num 1, pp 158-165, issn 0302-2838, 8 p.Article

Randomized, double-blind, placebo-and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladderYAMAGUCHI, Osamu; MARUI, Eiji; SEKI, Narihito et al.BJU international (Papier). 2007, Vol 100, Num 3, pp 579-587, issn 1464-4096, 9 p.Article

Solifenacin Is Able to Improve the Irritative Symptoms After Transurethral Resection of Bladder TumorsZHENSHENG ZHANG; ZHI CAO; YINGHAO SUN et al.Urology (Ridgewood, NJ). 2014, Vol 84, Num 1, pp 117-121, issn 0090-4295, 5 p.Article